Child with erythematous non-blanching bosselated lesion on right side of face, Treatment is
**Question:** Child with erythematous non-blanching bosselated lesion on right side of face, Treatment is
A. Antibiotics
B. Anti-fungal agents
C. Anti-histamines
D. Immunosuppressive drugs
**Core Concept:**
The clinical scenario described involves a child presenting with a non-blanching, bosselated erythematous lesion on the right side of the face. This presentation is indicative of a condition known as "rosacea," which is a chronic inflammatory skin disease affecting the facial skin, particularly the central face, leading to flushing, redness, and papules/pustules. The correct treatment options should address the primary pathophysiology of rosacea, which involves vascular dilatation, papulopustular lesions, and ocular involvement in severe cases.
**Why the Correct Answer is Right:**
The correct answer is B, "Anti-fungal agents," as rosacea is primarily a vascular and inflammatory condition rather than a fungal infection. While fungal infections may coexist with rosacea, they are not the primary cause. The other options are incorrect for the following reasons:
A. Antibiotics (option A): Although antibiotics are sometimes used to treat rosacea, they are not the first-line therapy as rosacea is not a bacterial infection. Antibiotics may be used for secondary infections but are not targeted at the primary vascular and inflammatory components of rosacea.
C. Anti-histamines (option C): Histamine is a mediator in the inflammatory response, but antihistamines are typically used to alleviate associated symptoms like pruritus and ocular symptoms rather than treating the primary pathophysiology of rosacea.
D. Immunosuppressive drugs (option D): Immunosuppressive drugs are not indicated in rosacea, as they are typically used to treat autoimmune diseases or transplant patients. Rosacea is a vascular and inflammatory condition, not an autoimmune or transplant-related disease.
**Why Each Wrong Answer is Incorrect:**
Antibiotics (option A) are not the primary treatment for rosacea because it is not a bacterial infection. They may be used to treat secondary infections, but the primary focus should be on addressing the vascular and inflammatory components of the disease.
Antihistamines (option C) are used to alleviate pruritus and ocular symptoms associated with rosacea. They do not address the vascular and inflammatory aspects of the disease.
Immunosuppressive drugs (option D) are typically used in autoimmune diseases or transplant patients, not for treating rosacea. Rosacea is a vascular and inflammatory condition, not an autoimmune or transplant-related disease.
**Core Concept:**
Rosacea is a multifactorial disorder involving multiple pathways, including vascular dilation, inflammation, and demodex infestation. The correct treatment addresses these pathophysiological factors, making option B (anti-fungal agents) the correct answer. These agents target demodex infestation, one of the contributing factors in rosacea development